CRL
Charles River Laboratories Inte
Diagnostics & Research · Healthcare · United States
281.27
close · 2026-08-13
value
63
cheaper than peers63
quality
13
stronger fundamentals13
ranked against
Diagnostics & Research
value
quality
28 peers
Value inputs
| measure | company | vs peers |
| EV to EBITDA | 18.33× | 68 |
| price to sales | 3.22× | 65 |
| price to book | 4.73× | 56 |
| forward P/E | 22.17× | 55 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 15.1% | 61 |
| return on equity | -7.5% | 33 |
| debt to equity | 105.0% | 21 |
| revenue growth | -2.7% | 9 |
4 of 4 measures available
Facts
| market cap | $14B |
| free cash flow | $468.9M |
| employees | 18,300 |
| first trade | 2000-06-23 |
| next earnings | 2026-08-05 |
| fundamentals updated | 2026-08-07 |